icon-    folder.gif   Conference Reports for NATAP  
 
  Conference on Retroviruses
and Opportunistic Infections
Seattle, Washington
Feb 19-22 2023
Back grey_arrow_rt.gif
 
 
 
CHARACTERIZATION OF SINGLE VERSUS DUAL ACTIVE MONOCLONAL ANTIBODIES AGAINST SARS-COV-2
 
 
  CROI 2023 Feb 20-23
 
Manish C. Choudhary
Brigham and Women's Hospital | Harvard Medical School Boston, MA, USA
 
there are ongoing efforts to develop the next generation of mAbs and this study shows proof-of-principle that dual-active mAb therapy offers virologic benefit over single-active mAbs. This will help inform the design and implementation for future mAb therapeutics.

0305231

0305232

0305233

0305234

0305235

0305236